Quadrant Private Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.4M Buy
2,610
+103
+4% +$104K 0.37% 79
2025
Q4
$2.69M Buy
2,507
+229
+10% +$219K 0.44% 66
2025
Q3
$1.74M Buy
2,278
+9
+0.4% +$6.7K 0.32% 82
2025
Q2
$1.77M Buy
2,269
+152
+7% +$118K 0.37% 74
2025
Q1
$1.75M Sell
2,117
-98
-4% -$81.5K 0.44% 68
2024
Q4
$1.71M Sell
2,215
-244
-10% -$202K 0.42% 64
2024
Q3
$2.18M Buy
2,459
+32
+1% +$28.8K 0.54% 57
2024
Q2
$2.2M Buy
2,427
+46
+2% +$36.8K 0.5% 57
2024
Q1
$1.85M Buy
2,381
+31
+1% +$22.1K 0.47% 61
2023
Q4
$1.37M Sell
2,350
-36
-2% -$21K 0.38% 69
2023
Q3
$1.28M Sell
2,386
-109
-4% -$56.2K 0.43% 62
2023
Q2
$1.17M Buy
2,495
+39
+2% +$16.4K 0.34% 74
2023
Q1
$844K Buy
2,456
+15
+0.6% +$5.06K 0.26% 90
2022
Q4
$893K Buy
+2,441
New +$865K 0.3% 85
2022
Q2
$767K Buy
2,366
+2
+0.1% +$600 0.31% 73
2022
Q1
$677K Sell
2,364
-2
-0.1% -$515 0.25% 88
2021
Q4
$654K Buy
2,366
+10
+0.4% +$2.54K 0.24% 90
2021
Q3
$544K Buy
2,356
+22
+0.9% +$5.43K 0.22% 97
2021
Q2
$536K Sell
2,334
-5
-0.2% -$1K 0.22% 99
2021
Q1
$437K Sell
2,339
-194
-8% -$37.9K 0.19% 114
2020
Q4
$428K Sell
2,533
-523
-17% -$78.1K 0.19% 110
2020
Q3
$452K Buy
3,056
+10
+0.3% +$1.55K 0.23% 94
2020
Q2
$500K Buy
3,046
+541
+22% +$83K 0.29% 79
2020
Q1
$348K Buy
2,505
+550
+28% +$75.6K 0.29% 81
2019
Q4
$257K Hold
1,955
0.23% 91
2019
Q3
$219K Buy
1,955
+1
+0.1% +$111 0.2% 99
2019
Q2
$217K Hold
1,954
0.2% 96
2019
Q1
$254K Sell
1,954
-5
-0.3% -$608 0.23% 88
2018
Q4
$227K Hold
1,959
0.24% 83
2018
Q3
$210K Buy
+1,959
New +$196K 0.18% 91

Other funds holding LLY

Quadrant Private Wealth Management's LLY Position: Q1 2026 in Review

Quadrant Private Wealth Management increased its Eli Lilly (LLY) stake by 4.1% in Q1 2026, buying an estimated $104K and bringing the position to 2,610 shares worth $2.4M. The position accounts for 0.37% of the portfolio, ranked #79.

Quadrant Private Wealth Management first reported a position in LLY in Q3 2018 and has held it in 30 quarters since. The position peaked at $2.69M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Quadrant Private Wealth Management held 2,610 shares of Eli Lilly worth $2.4M as of Q1 2026.
  • Quadrant Private Wealth Management bought 103 Eli Lilly shares in Q1 2026, an estimated $104K.
  • Eli Lilly made up 0.37% of Quadrant Private Wealth Management's portfolio in Q1 2026, its #79 holding.
  • Quadrant Private Wealth Management first reported a position in Eli Lilly in Q3 2018 and has held it in 30 quarters since.
  • Quadrant Private Wealth Management's Eli Lilly position peaked at $2.69M in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Quadrant Private Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.